Vascular endothelial is considered to be a key factor in the pathogenesis of erectile
dysfunction (ED). The purpose is to reveal the research trend of the field of ED and vascular …

Erectile dysfunction is observed in about 50% of men. It has been found that diabetes
mellitus increases its prevalence to 19-86.3%, necessitating attention to a therapeutic …

Background The causal relationship between certain immune cells and erectile dysfunction
(ED) is still uncertain. Aim The study sought to investigate the causal effect of 731 types of …

Background: The improvement of absent or partial response in the medical treatment of
erectile dysfunction (ED) has led to the development of minimally invasive new treatment …

Aim: This study has the primary objective of studying the effect of Wharton jelly
mesenchymal stem cells (WJMSCs) in the treatment of knee osteoarthritis. As a secondary …

Introduction While phosphodiesterase type 5 inhibitors (PDE5is) and others are used to treat
Erectile dysfunction (ED), many patients are either unresponsive or resistant to it. Stem cell …

Introduction Erectile dysfunction (ED) is a common condition that negatively affects men's
quality of life. It can have various causes, including psychological, vascular, and neurologic …

Multiple system atrophy (MSA) is a sporadic, fatal, and rapidly progressive
neurodegenerative disease of unknown etiology that is clinically characterized by autonomic …

Current noninvasive treatments for erectile dysfunction (ED) include oral medications,
intracavernosal injections, and vacuum-assisted devices. Although these therapies work …

Objectives Diabetes mellitus (DM) is a complex metabolic disease that results from impaired
insulin secreting pancreatic β-cells or insulin resistance. Although available medications …